Compare NKTX & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NKTX | DPRO |
|---|---|---|
| Founded | 2015 | 1998 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 147.7M | 169.4M |
| IPO Year | 2020 | N/A |
| Metric | NKTX | DPRO |
|---|---|---|
| Price | $1.81 | $6.89 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | $13.25 | ★ $15.67 |
| AVG Volume (30 Days) | 684.9K | ★ 2.0M |
| Earning Date | 11-10-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $5,335,758.00 |
| Revenue This Year | N/A | $39.47 |
| Revenue Next Year | N/A | $155.03 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 26.74 |
| 52 Week Low | $1.31 | $1.63 |
| 52 Week High | $3.16 | $14.40 |
| Indicator | NKTX | DPRO |
|---|---|---|
| Relative Strength Index (RSI) | 40.37 | 42.81 |
| Support Level | $1.77 | $6.42 |
| Resistance Level | $1.93 | $7.70 |
| Average True Range (ATR) | 0.09 | 0.78 |
| MACD | 0.01 | -0.01 |
| Stochastic Oscillator | 30.00 | 34.81 |
Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.
Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.